Market News & Trends
Novozymes’s Recombinant Human Albumin Helps Innovative Dry Eye Therapy
Novozymes Biopharma recently announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA. Designed…
ApoCell Announces Delivery of First Prototypes of ApoStream CTC Isolation Technology
ApoCell, Inc. recently announced that the first prototypes of its ApoStream circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including…
MultiCell Technologies Files Patent Application to Achieve Targeted Tumor Cell Death
MultiCell Technologies, Inc. recently announced the filing of a US patent application concerning methods and formulations to achieve targeted tumor cell death. MCT-485 is a…
RBCC May Enter $142-Billion Drug Delivery Market
As part of the company’s push to carve out a share of the $142-billion US drug delivery market, Rainbow Coral Corp. opened talks this week…
J&J Expects More Than 10 NDAs
Johnson & Johnson recently announced it is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval…
Catalent Applied Drug Delivery Institute Announces Winners of Academic Competition
The academic competition aims to identify emerging scientific talent, foster drug delivery education, and reward academic excellence. Winners were chosen from leading US and European…
AmerisourceBergen Corporation Completes $308-Million Divestiture
Frazier Healthcare and Packaging Coordinators, Inc. recently announced it has completed the acquisition of pharmaceutical packager AndersonBrecon from its parent company AmerisourceBergen Corporation. AndersonBrecon will…
Theravance & Elan Sign $1-Billion Agreement
Theravance, Inc. and Elan Corporation, plc recently announced they have entered into a royalty participation agreement wherein Elan will purchase a participation interest in potential…
Arbor Pharmaceuticals Announces FDA Approval
Arbor Pharmaceuticals recently announced that the US FDA has approved its New Drug Application (NDA) for Nymalize (nimodipine) oral solution. Nymalize was previously granted Orphan…
Cempra & Toyama Sign $70-Million License & Development Agreement
Cempra, Inc. recently announced the signing of an exclusive license and development agreement for solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings…
Bend Research Expands Analytical Sciences & Capacity
Bend Research Inc. recently announced it has expanded its Good Manufacturing Practice (GMP) analytical capabilities and capacity for pharmaceutical development. Coupled with the company’s existing…
Dyax Announces $30 Million Offering
Dyax Corp. recently announced it has priced a registered direct offering with RA Capital Management, Venrock, Federated Investors, Inc. and one other institutional investor for…
Andain Announces Innovative Organ-Targeted Drug Delivery Nanoparticles
Andain Inc. recently announced its innovative nanoparticles drug delivery technology. Andain completed the development of innovative lipid-based drug delivery nanoparticles capable of carrying hydrophilic and…
Sagent Pharma to Acquire Remaining Interest in Company for $25 Million
Sagent Pharmaceuticals, Inc. recently announced an agreement to acquire the 50% interest of its joint venture partner, Chengdu Kanghong Pharmaceuticals (Group) Co. Ltd. formerly Chengdu…
Concert Pharmaceuticals & Celgene Sign $300-Million Tech Deal
Concert Pharmaceuticals, Inc. recently announced it has entered into a strategic collaboration with Celgene Corporation directed toward deuterium-modified compounds targeting cancer and inflammation. The collaboration…
Astellas Pharma & Drais Pharmaceuticals to Launch Virtual Co.
Astellas Pharma Inc. and Drais Pharmaceuticals, Inc.recently announced they have entered into a third partnership in the past year to develop and commercialize an Astellas…
Arena Pharmaceuticals Receives $65 Million From Eisai
Arena Pharmaceuticals, Inc. recently announced that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing…
Recipharm & Synthonics Join Forces to Promote Delivery Technology
Recipharm Pharmaceutical Development AB and Synthonics, Inc. recently announced the formation of a Joint Promotion Agreement. The contract, the first of its kind to be…
PAREXEL International Acquires HERON Group
PAREXEL International Corporation recently announced it has acquired all of the outstanding equity securities of the HERON Group LTD, a life sciences consultancy that provides…
Pharma & Biotech Industries Headed Toward an Era of Reduced Profit Margins
In the face of reduced profit margins for the pharmaceutical and biotechnology sectors, an effective financial management strategy is central to maintain sustainable growth. New…
